Why CrowdStrike stock is sliding today: CRWD hit by tariff jitters despite new cloud plan
20 January 2026
1 min read

Why CrowdStrike stock is sliding today: CRWD hit by tariff jitters despite new cloud plan

New York, Jan 20, 2026, 14:19 EST — Regular session

  • CrowdStrike shares dropped roughly 3% amid a widespread risk-off selloff dragging down tech stocks.
  • The company unveiled plans to launch new in-country clouds in Saudi Arabia, India, and the UAE.
  • Traders are focused on this week’s inflation numbers and the Fed meeting next week for the market’s next move.

CrowdStrike Holdings, Inc. shares dropped 2.8% to $441.18 in Tuesday afternoon trading, retreating despite the cybersecurity firm’s announcement of a new effort to boost regional cloud capacity.

The move is significant as “data sovereignty” — rules mandating sensitive data remain within national borders — increasingly block major security contracts. Vendors providing local data storage while maintaining access to global threat intelligence typically hold an advantage in regulated markets.

The tape looked rough. Investors fled growth stocks as Wall Street dipped following President Donald Trump’s threat of new tariffs on several European nations connected to the Greenland dispute. An LPL Financial strategist dismissed the tariff talk as “just a negotiation tool.” 1

CrowdStrike announced plans to roll out new regional cloud setups in Saudi Arabia, India, and the United Arab Emirates under its Global Data Sovereignty initiative. The company said more locations will be added later. CEO George Kurtz emphasized, “Data sovereignty requirements cannot come at the cost of AI-powered security.” 2

Simply put, the company aims to keep customers’ security data local but still offer a unified platform across regions. This is crucial for government projects, critical infrastructure, and tightly regulated sectors, where the data’s location can derail a deal before it even gets off the ground.

Cybersecurity stocks dipped across the board. Zscaler dropped around 2.8%, Palo Alto Networks slid about 1.3%, and Fortinet edged down roughly 0.3%.

The risk, as always, lies in execution. Building out cloud infrastructure locally can drag on, face compliance snags, and rack up costs before turning a profit. On days like today, the market pays more attention to rates, politics, and risk appetite than product positioning.

Investors now turn to the macro calendar, eyeing the Personal Consumption Expenditures price index, a key inflation measure the Federal Reserve follows. It’s set for release on Jan. 22. 3

The Federal Reserve’s policy meeting on Jan. 27-28 is next, with the key decision coming Jan. 28. This date often rattles high-multiple software stocks, especially if there’s any change in rate expectations. 4

Stock Market Today

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

8 February 2026
Cambricon Technologies shares closed at 1,036.99 yuan in Shanghai on Friday, down 2.02%, with volume at about 8 million shares. The stock has fallen roughly 16.5% since Feb. 2 after sharp declines earlier in the week. Investors await the company’s next earnings report, due March 13, for confirmation of its forecasted profit turnaround. Cambricon is valued at about 437.28 billion yuan.
Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

8 February 2026
Infineon shares closed up 1.5% at 42.04 euros Friday on Xetra after reports the company plans April price hikes on some power products. TrendForce said the increases, citing tight supply and higher costs, would apply from April 1. The Feb. 12 record date and Feb. 19 annual meeting are next for shareholders. UBS raised its price target to 47 euros, citing stronger margins.
Morgan Stanley stock price slides as credit-card rate cap deadline weighs on banks
Previous Story

Morgan Stanley stock price slides as credit-card rate cap deadline weighs on banks

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play
Next Story

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Go toTop